CD69 + Vδ1γδ T cells are anti-tumor subpopulations in hepatocellular carcinoma

Hongqin You,Yixin Wang,Xiaokun Wang,Huifang Zhu,Yajie Zhao,Peng Qin,Xue Liu,Mengyu Zhang,Xiaomin Fu,Benling Xu,Yong Zhang,Zibing Wang,Quanli Gao
DOI: https://doi.org/10.1016/j.molimm.2024.06.006
IF: 4.174
2024-06-27
Molecular Immunology
Abstract:Background & aims Hepatocellular carcinoma (HCC), one of the malignancies with a wide expression of stress ligands recognized by Vδ1γδ T cells, has received much attention in adoptive immunotherapy of γδ T cells. In this study, we aimed to identify the potential anti-tumor Vδ1γδ T subpopulations in HCC. Methods Healthy donors (HDs) and HCC patients were recruited from the Affiliated Cancer Hospital of Zhengzhou University. Blood and tumor tissue samples were obtained respectively. Bioinformatics methods were used to analyze total γδ T cells and subsets infiltration, overall survival of HCC patients with high and low infiltration level of Vδ1γδ T cells, and IFNG , granzyme A, granzyme B and perforin expression in TRDV1 high/low CD69 high/low groups. CD69 expression and Vδ1γδT cells infiltration in HCC were detected by immunofluorescence. Phenotypic analysis of Vδ1γδ T cells in blood and tumor tissue samples were performed by flow cytometry. Results Vδ1γδ T cells infiltrating in HCC were associated with better clinical outcome. Study in tumor micro-environment (TME) of HCC demonstrated that not total Vδ1γδ T but CD69 + Vδ1γδ subset infiltration was associated with smaller tumor volume. Moreover, HCC patients simultaneously with high TRDV1 and CD69 expression produced more effector molecules and had longer survival time. Since Vδ1γδ T cells in the tumor microenvironment were often difficult to access, we demonstrated that CD69 + Vδ1γδ T cells also existed in peripheral blood mononuclear cells (PBMC) of HCC and displayed enhanced cytotoxic potentials than HDs. Finally, we investigated the functions and found that CD69 + Vδ1γδ T cells exhibited stronger tumor reactivities when challenged by tumor cells. Conclusions CD69 + Vδ1γδ T cells are functional Vδ1γδ T cell subsets in patients with HCC. Circulating CD69 + Vδ1γδ T cell is a promising candidate in immunotherapy of HCC.
biochemistry & molecular biology,immunology
What problem does this paper attempt to address?